ADVANCED SOLID TUMORS (EXCLUDING GASTRIC CANCER AND BREAST CANCER)

Clinical trials for ADVANCED SOLID TUMORS (EXCLUDING GASTRIC CANCER AND BREAST CANCER) explained in plain language.

Never miss a new study

Get alerted when new ADVANCED SOLID TUMORS (EXCLUDING GASTRIC CANCER AND BREAST CANCER) trials appear

Sign up with your email to follow new studies for ADVANCED SOLID TUMORS (EXCLUDING GASTRIC CANCER AND BREAST CANCER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo tested for Tough-to-Treat cancers

Disease control Recruiting now

This study is testing an experimental drug called trastuzumab deruxtecan (T-DXd), either alone or combined with other cancer drugs, for people with advanced solid tumors that have a specific marker called HER2. The goal is to see if the treatment can shrink tumors and control the…

Matched conditions: ADVANCED SOLID TUMORS (EXCLUDING GASTRIC CANCER AND BREAST CANCER)

Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ADVANCED SOLID TUMORS (EXCLUDING GASTRIC CANCER AND BREAST CANCER)

Get alerted when new ADVANCED SOLID TUMORS (EXCLUDING GASTRIC CANCER AND BREAST CANCER) trials appear

New drug combo tested for Tough-to-Treat cancers